Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease

Fig. 1

Phenotype and function of circulating CD34+ cells. a The absolute number of MF patients subdivided into JAK2V617F-mutated (grey column, n = 18) or TN (blue column, n = 6) groups. CD34+ cells co-expressing the CD184, CD133, CD63 antigens are shown. Percentage of Annexin V/PI negative (survival) CD34+ cells (b), CFU-C counts (c), and migration as input (d) of cells cultured in vitro over-night. All data are presented as mean ± SEM (*p ≤ 0.05)

Back to article page